α-Blocker Plus Diuretic Combination Therapy as Second-line Treatment for Nocturia in Men With LUTS: A Pilot Study

Urology

Volumn 73, Issue 3, 2009, Pages 549-553

  Cho, Min Chul ^a   Ku, Ja Hyeon ^a   Paick, Jae Seung ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCHLOROTHIAZIDE; TERAZOSIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; HYPERTENSION; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; NOCTURIA; PILOT STUDY; POLYURIA; PRIORITY JOURNAL; URINARY FREQUENCY;

ADRENERGIC ALPHA-ANTAGONISTS; AGED; DIURETICS; DRUG THERAPY, COMBINATION; HUMANS; HYDROCHLOROTHIAZIDE; MALE; NOCTURIA; PILOT PROJECTS; PRAZOSIN; PROSPECTIVE STUDIES; PROSTATISM;

EID: 60549110468     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.08.517     Document Type: Article

References (24)

1. Rodney A.A., and Peter K.S. Nocturia: etiology, diagnosis, and treatment. Neurourol Urodyn 27 (2008) 34-39
2. Asplund R., and Aberg H. Health of the elderly with regard to sleep and nocturnal micturition. Scand J Prim Health Care 10 (1992) 98-104
3. Paick J.S., Ku J.H., Shin J.W., et al. Alpha-blocker monotherapy in the treatment of nocturia in men with lower urinary tract symptoms: a prospective study of response prediction. BJU Int 97 (2006) 1017-1023
4. Reynard J.M., Cannon A., Yang Q., et al. A novel therapy for nocturnal polyuria: a double-blind randomized trial of furosemide against placebo. BJU Int 81 (1998) 215-218
5. van Kerrebroeck P., Abrams P., Chaikin D., et al. The standardisation of terminology in nocturia: report from the Standardisation Sub-Committee of the International Continence Society. Neurourol Urodyn 21 (2002) 179-183
6. Weiss J.P., Blaivas J.G., Stember D.S., et al. Nocturia in adults: etiology and classification. Neurourol Urodyn 17 (1998) 467-472
7. Miller M. Nocturnal polyuria in older people: pathophysiology and clinical implications. J Am Geriatr Soc 48 (2000) 1321-1329
8. Andersson K.E. The pharmacological treatment of nocturia. BJU Int 90 suppl 3 (2002) 25-27
9. Rembratt A., Abrams P., and van Kerrebroeck P. Desmopressin in elderly patients with nocturia: short-term safety and effects on urine output, sleep and voiding pattern. BJU Int 91 (2004) 642-646
10. Chobanian A.V., Bakris G.L., Black H.R., et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289 (2003) 2560-2572
11. Chobanian A.V., Bakris G.L., Black H.R., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 (2003) 1206-1252
12. McKeigue P.M., and Reynard J.M. Relation of nocturnal polyuria of the elderly to essential hypertension. Lancet 355 (2000) 486-488
13. Tanaka Y., Masumori N., Itoh N., et al. Urodynamic effects of terazosin treatment for Japanese patients with symptomatic benign prostatic hyperplasia. J Urol 167 (2002) 2492-2495
14. Okada H., Kamidono S., Yoshioka T., et al. A comparative study of terazosin and tamsulosin for symptomatic benign prostatic hyperplasia in Japanese patients. BJU Int 85 (2000) 676-681
15. Lee E., and Lee C. Clinical comparison of selective and non-selective alpha 1A adrenoreceptor antagonists in benign prostatic hyperplasia: studies on tamsulosin in a fixed dose and terazosin in increasing doses. Br J Urol 80 (1997) 606-611
16. Uzu T., and Kimura G. Diuretics shift circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation 100 (1999) 1635-1638
17. Charles F.L., Lora L.A., Morton P.G., et al. Drug Information Handbook. 13th ed. (2005), Lexi-Comp, Hudson 753-754
18. Mattiasson A., Abrams P., Van Kerrebroeck P., et al. Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men. BJU Int 89 (2002) 855-862
19. Van Kerrebroeck P., Rezapour M., Cortesse A., et al. Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study. Eur Urol 52 (2007) 221-229
20. Hansen B.J., Meyhoff H.H., Nordling J., et al. Placebo effects in the pharmacological treatment of uncomplicated benign prostatic hyperplasia. Scand J Urol Nephrol 30 (1996) 373-377
21. McCormack M., Infante-Rivard C., and Schick E. Agreement between clinical methods of measurement of urinary frequency and functional bladder capacity. Br J Urol 69 (1992) 17-21
22. Homma Y., Yamaguchi T., Kondo Y., et al. Significance of nocturia in the international prostate symptom score for benign prostatic hyperplasia. J Urol 167 (2002) 172-176
23. Asplund R., Sundberg B., and Bengtsson P. Oral desmopressin for nocturnal polyuria in elderly subjects: a double-blind, placebo-controlled randomized exploratory study. BJU Int 83 (1999) 591-595
24. Drake M.J., Mills I.W., and Noble J.G. Melatonin pharmacotherapy for nocturia in men with benign prostatic enlargement. J Urol 171 (2004) 1199-1202